Ani Pharmaceuticals Inc (ANIP) — 10-Q Filings
All 10-Q filings from Ani Pharmaceuticals Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
- 10-Q Filing — May 8, 2026
-
ANI Pharma Swings to Profit on Soaring Revenue, Strong Cash Position
— Nov 7, 2025 Risk: medium
ANI Pharmaceuticals, Inc. reported a significant financial turnaround for the nine months ended September 30, 2025, with net revenues surging to $636.3 million, -
ANI Pharma Swings to Q2 Loss Amidst Retained Earnings Dip
— Aug 8, 2025 Risk: high
ANI Pharmaceuticals Inc. reported a net loss of $1.5 million for the three months ended June 30, 2025, a significant decline from a net income of $1.2 million i -
ANI Pharmaceuticals Q1 2025 Filing
— May 9, 2025 Risk: low
ANI Pharmaceuticals Inc. reported its first quarter results for the period ending March 31, 2025. The company's filing indicates a fiscal year end of December 3 -
ANI Pharmaceuticals Files Q3 2024 Report
— Nov 8, 2024 Risk: low
ANI Pharmaceuticals Inc. reported its third-quarter results for the period ending September 30, 2024. The company's filing indicates a fiscal year end of Decemb -
ANI Pharmaceuticals Reports Q1 2024 Results
— May 10, 2024 Risk: low
ANI PHARMACEUTICALS INC (ANIP) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. ANI Pharmaceuticals filed its 10-Q for the period ending March 31,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX